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Background: Active case detection (ACD) significantly contributes to early detection and treatment of visceral
leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) cases and is cost effective. This paper evaluates
the performance and feasibility of adapting ACD strategies into national programs for VL elimination in Bangladesh,
India and Nepal.
Methods: The camp search and index case search strategies were piloted in 2010-11 by national programs in high
and moderate endemic districts / sub-districts respectively. Researchers independently assessed the performance
and feasibility of these strategies through direct observation of activities and review of records. Program costs were
estimated using an ingredients costing method.
Results: Altogether 48 camps (Bangladesh-27, India-19, Nepal-2) and 81 index case searches (India-36, Nepal-45)
were conducted by the health services across 50 health center areas (Bangladesh-4 Upazillas, India-9 PHCs, Nepal-37
VDCs). The mean number of new case detected per camp was 1.3 and it varied from 0.32 in India to 2.0 in
Bangladesh. The cost (excluding training costs) of detecting one new VL case per camp varied from USD 22 in
Bangladesh, USD 199 in Nepal to USD 320 in India. The camp search strategy detected a substantive number of
new PKDL cases. The major challenges faced by the programs were inadequate preparation, time and resources
spent on promoting camp awareness through IEC activities in the community. Incorrectly diagnosed splenic
enlargement at camps probably due to poor clinical examination skills resulted in a high proportion of patients
being subjected to rK39 testing.
Conclusion: National programs can adapt ACD strategies for detection of new VL/PKDL cases. However adequate
time and resources are required for training, planning and strengthening referral services to overcome challenges
faced by the programs in conducting ACD.
Keywords: Visceral leishmaniasis, Kala-azar, Post kala-azar dermal leishmaniasis, Active case detection, Elimination
progamme, Bangladesh, India, Nepal* Correspondence: mhuda83@icddrb.org
1Centre for Communicable Diseases, icddr,b, Dhaka, Bangladesh
Full list of author information is available at the end of the article
© 2012 Huda et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Huda et al. BMC Public Health 2012, 12:1001 Page 2 of 7
http://www.biomedcentral.com/1471-2458/12/1001Background
The global burden estimate for Visceral leishmaniasis
(VL) also known as kala-azar in the Indian sub-contin-
ent, is 0.5 and 2.5 million incident and prevalent cases
per year, respectively [1]. With an estimated 200 million
people at risk, India, Nepal and Bangladesh harbour an
estimated 67% of the global VL disease burden [2]. In
this region, Leishmania donovani is the only species
causing VL, the female sand fly Phlebotomas argentipes
is the only vector and humans are the only known reser-
voir [3-5]. These unique characteristics, recent advances
in rapid field based diagnostics and availability of effect-
ive and safe oral drugs make the disease a target for
elimination (reducing incidence to less than one per
10,000 population by 2015) [6]. National programs for
kala-azar elimination (NKEP) were launched in 2005 by
Bangladesh, India and Nepal. One of the main strategies
is early case detection and management of VL and Post
Kala-azar Dermal Leishmaniasis (PKDL) [7]. Campaigns
were recently undertaken by the NKEP in Bangladesh.
In India, fortnight-long campaigns are carried out annu-
ally to raise VL awareness in endemic districts. The
NKEP in Nepal has strategies of active case detection
(ACD) including camp approach and index case ap-
proach. The District / Upazilla (Sub-district) level health
workers have been trained in ACD in the program. The
World Health Organization, Special program for Trop-
ical Diseases Research (TDR) is supporting operational
research in these three countries in consultation with na-
tional and state VL elimination programs. VL incidence
in 2006-07 ranged between 9 (in Nepal) to about 30 per
10,000 population in endemic districts of India and Ban-
gladesh [8]. Though community awareness of VL is high
(except in Bangladesh), diagnosis is delayed by several
weeks, treatment interruption is frequent, compliance is
low, and health provider’s knowledge about VL is limited.
ACD significantly contributes to detecting more VL and
PKDL cases, early diagnosis and early onset of treatment
and lower costs for patients [9]. The need for ACD is
enhanced by the advent of a new form of treatment, lipo-
somal Amphotericine B (Ambisome, ™) which is highly
effective and can be implemented in small hospitals [10]. A
comparison of cost-effectiveness of four different strategies
for ACD including Camp strategy (fever camps with spleen
examination and rapid diagnostic test (rK39)), Index case
(focal) strategy (house to house screening in the neighbor-
hood of recent VL cases), Incentive based strategy (case
detection through village health workers who receive an in-
centive for every new case) and house to house screening
strategy (as reference approach) shows 80% sensitivity for
the camp approach with high cost-effectiveness. The Index
case approach is also cost effective but has lower sensitiv-
ity (only few new cases detected in the neighborhood of
known VL cases). The Incentive based approach showshigh cost-effectiveness in India and Nepal but is not prac-
tical in Bangladesh [11]. NKEPs need the right combin-
ation of different ACD strategies based on the
epidemiological profile, affordability and organizational
feasibility.
The Kala-azar Regional Technical Advisory Group
(RTAG) recommends the adoption of ACD strategies
into NKEPs through the existing health services at sub-
district level [12]. In this paper, we assess the perform-
ance and feasibility of two known cost-effective ACD
strategies i.e. camp and index case search as implemen-
ted by the health services, and provide evidence for pol-
icies to improve VL case detection in national programs.
Methods
Ethics statement
The study was approved by the Ethics Committees of all
participating institutes (Ethics Committee, Rajendra Me-
morial Research Institute of Medical Sciences, India;
Ethics Committee, Institute of Medical Sciences, Banaras
Hindu University, India; Institutional Review Board, In-
stitute of Medicine, Tribhuvan University, Nepal; Ethics
Review Committee, icddr,b, Bangladesh; and Ethics Re-
view Committee, World Health Organization). Subjects
participated in the research after a written informed
consent.
Study area and study design
Known VL endemic Upazillas/Primary health centers
(PHCs) in Bangladesh and India were categorized into
high, moderate and low endemicity. As per national
guideline in Bangladesh the high, moderate and low en-
demicity is defined as VL incidence >2.5, >1.1 to ≤2.5,
and <1 per 10,000 population respectively at Upazilla
level. In India, VL incidence was calculated based on past
one year case load at PHC level and the level of endem-
icity was defined as high (Incidence >4 per 10,000 pop-
ulation), moderate (1 to 4 per 10,000) and low (< 1 per
10,000). The camp strategy was conducted in areas with
high VL endemicity and the index case strategy in areas
with moderate VL endemicity. In Nepal with relatively
low VL incidence, according to the national program
guidelines, index case search was carried out in villages/
toles which reported a new VL case in the last one year
while villages which reported higher number of VL cases
were selected for the camp search strategy. ACD was
conducted by the existing health system and its perform-
ance was evaluated independently by the research teams
in the study area.
Pre-intervention
As a first step, the Kala-azar RTAG comprising of inter-
national and national experts and country program man-
agers from Bangladesh, India and Nepal were presented
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recent operational research undertaken by the authors.
RTAG in turn urged member states to adapt these re-
commendations into their country programs.
A VL case was defined following national guidelines as
a person from an endemic area with fever for more than
2 weeks, splenomegaly and a positive rK39 test. A PKDL
case was defined following national guidelines as a per-
son with past history of VL presenting with maculo-
papular or nodular skin lesions and a positive rK39 test.
Detailed standard operating procedures (SOPs) for camp
and index case search strategies were developed in con-
sultation with national and state level program managers
for standardizing the interventions as much as possible.
After extensive consultations, the countries decided to
pilot these interventions at district / sub-district level.
Training materials and courses were developed and
adapted in the local language for district and health cen-
ter level functionaries as well as community based health
volunteers.
Intervention
The camp search and the index case search strategy
were implemented by the health services in the period
March - April, 2010 in Bangladesh and July 2010 - April,
2011 in India and Nepal. The index case search strategy
was not implemented in Bangladesh as it was yet to be
adopted by the national health authorities.
Camps were scheduled 15-30 days in advance under
the aegis of the medical officer of the health center. In
India and Nepal, camps were held in the main center of
the village and in Bangladesh also in the EPI centers or
primary schools. Camps were promoted 1 to 2 days be-
fore by health workers and community based health
volunteers through house to house visits and public ad-
dress systems (miking) inviting people with fever more
than 2 weeks or known past cases of VL with skin le-
sions to get examined at the camp. Photographs of skin
lesions were displayed to create awareness about PKDL.
Camps were conducted by a team of 4 to 10 members
comprising of medical officer, laboratory technician,
health supervisor, health workers and community based
health volunteers like accredited social health activists
and anganwadi workers in India. Patients with fever for
more than 2 weeks were examined for spleen enlarge-
ment by the medical officer and rK39 tests (Kala-azar
Detect from InBios International, USA) performed if VL
was suspected. A known past case of VL with PKDL-like
skin lesions was tested for rK39 test. VL and PKDL cases
identified were referred to the local health centers or
hospitals for initiation and monitoring of treatment. A
roster of camp attendees, case referral forms and records
of newly detected VL / PKDL patients was maintained at
the health center.An index case was defined as a recently (within last
12 months) diagnosed or current VL case. A list of index
cases was made and index cases were traced at their
homes by the health staff. All households within a 50-
75 m radius (about 100 households) of the index case
household were screened by health workers. Any house-
hold member identified with fever for more than 2 weeks
or any known VL case with suspected skin lesions was
referred to the health center for spleen examination and
rK39 testing and management. Record of newly diag-
nosed VL/PKDL patients was maintained at the health
center.Evaluation of intervention
The intervention was independently evaluated by re-
searchers while it was ongoing. In India, 4 sub-centers
each were randomly selected for evaluation from 7 high
and 2 moderate endemic PHCs. In Nepal, 2 high and
35 moderately endemic Village development councils
(VDCs) were randomly selected while in Bangladesh
which implemented only the camp search strategy, 4
high endemic Upazillas were selected for evaluation. In
India and Nepal, the performance of the camp and index
case search was assessed by the yield of newly diagnosed
VL / PKDL cases, as well as through structured observa-
tions by researchers present before, during and following
camp or index case search activities. Activities done as
per national guidelines and SOPs were defined as ad-
equate or inadequate if otherwise. In Bangladesh, due to
late release of funds by the government, camps were
scheduled quickly by the program managers and the
researchers came to know about the camps only after
they were held. As a result, in Bangladesh the camp
search strategy could be assessed only in retrospect
based on interviews of medical officers who had con-
ducted the camps and review of records. The research
team in Bangladesh also conducted a screening of all
households for identifying individuals with fever for
more than 2 weeks, splenomegaly and positive rK39 test
in one randomly selected camp catchment area (6 vil-
lages) where a camp had been held earlier to determine
the sensitivity of the camp search in identifying new VL
cases existing in the community. Furthermore, new VL
cases identified by the house to house screening but who
had not participated in the camp were also interviewed
to seek reasons for not participating in the camp held
earlier.
The program cost for implementing the camp and in-
dex case search strategies was estimated using an ingre-
dients costing method. Costing ingredients included
costs for training, development and production of train-
ing materials, rK39 kits, per diem costs and costs for
transport, communication and materials.
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Data was entered and managed centrally using EPI Info
software. Simple descriptive (means and proportions)
summary statistics and tests of significance for difference
in means and proportions were estimated. Sensitivity of
the camp in Bangladesh was calculated as the percentage
of new VL cases identified by the camp out of the total
of new cases identified by the camp and the additional
new cases identified in the house to house search.
Results
Performance and feasibility
Altogether 48 camps (Bangladesh-27, India-19 and
Nepal-2) and 81 index case searches (India-36, Nepal-45)
were conducted by the health services across 50 health
center areas (Bangladesh-4 Upazillas, India-9 PHCs and
Nepal-37 VDCs). Patients with fever for more than
2 weeks or known VL cases with skin lesions attending
camps varied (mean - 12.9, range - 1 to 50 in Bangladesh;
mean - 11.8, range - 2 to 30 in India; and mean - 29.5,
range - 24 to 35 in Nepal). Male attendance at camps
(range 48 to 56%) was similar across the 3 countries
(Table 1). Camp attendees were younger by 5 years in
Bangladesh (mean age 27.4 years) compared to India
and Nepal (P-value <0.0001). Of the 225 camp attendees,
193 were recorded to have fever plus splenomegaly ofTable 1 Camp search intervention carried out by health servi
Bangladesh
No. of camps held 27
Mean no. of camp attendees$ (range) 12.9 (01 – 50)
% (No.) male 48% (168/349
Mean (SD) age in years 27.4 (19.1)
Detection of VL
- with splenomegaly 52% (183/349
- rK39 test done 100% (183/18
- rK39 positive 22% (40/183)
- referred for treatment 100% (40/40)
- completed treatment 33% (13/40)
- No. of new VL cases detected 40
- No. of new VL cases detected per camp 1.5
Detection of PKDL
- with suspected skin lesions 5% (17/349)
- rK39 test done 100% (17/17)
- rK39 test positive 82% (14/17)
- referred for treatment 100% (14/14)
- completed treatment 0% (0/14)
- No. of new PKDL cases detected 14
- No. of new PKDL cases detected per camp 0.5
No. of new cases (VL + PKDL) detected 54
No. of new cases detected per camp 2.0
$Camp attendees with fever for more than 2 weeks or past case of VL with skin lesiwhom 5 (2.6%) tested positive for rK39 test in India
compared to 22% of patients with fever and splenomeg-
aly tested positive for rk39 test in Bangladesh. On the
other hand, in Nepal, 3 of 59 (5%) patients with fever for
more than 2 weeks had splenomegaly, all of whom were
positive for rK39 test. The camp search strategy yielded
40 new VL cases in Bangladesh (mean 1.5 new VL case
per camp) compared with 5 (mean 0.3) and 3 (mean 1.5)
new VL cases in India and Nepal respectively. Addition-
ally in Bangladesh, 14 new PKDL cases were identified
in the camps compared to one in India and none in
Nepal. All newly identified cases in India and Nepal
completed treatment. In Bangladesh, 13 of 40 (32.5%)
VL cases completed their treatment (Table 1). Treatment
completion could not be ascertained for the remaining
27 VL cases and all of the 14 PKDL cases in Bangladesh
as they were lost to follow-up. In the single camp catch-
ment area (6 villages) in Bangladesh where the camp
was followed by screening of all households in the vil-
lage, 13 new cases (6 new VL and 7 new PKDL cases)
were identified in addition to 9 new cases (3 new VL
and 6 new PKDL cases) identified earlier in the camp
giving an overall sensitivity of 41% (95% CI, 21% – 63%)
for the camp search strategy when compared with the
house to house screening strategy (results not shown).
None of the 13 new cases identified subsequently in theces in Bangladesh, India and Nepal
India Nepal
19 2
11.8 (02 – 30) 29.5 (24 – 35)
) 52.9% (119/225) 56% (33/59)
33.1 (18.5) 33.8 (20.3)
) 85.8% (193/225) 5% (3/59)
3) 100% (193/193) 100% (3/3)
2.6% (5/193) 100% (3/3)
100% (5/5) 100% (3/3)
100% (5/5) 100% (3/3)
5 3
0.3 1.5
2.2% (5/225) 0% (0/59)
100% (5/5) –
20% (1/5) –
100% (1/1) –
100% (1/1) –
1 0
.05 0
6 3
0.32 1.5
ons.
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camp. Qualitative assessment (structured observations)
of the camp search strategy showed adequate prepara-
tory activities (training, scheduling, selection of location
etc.) except in India where information education and
communication (IEC) activities in the community were
inadequate to promote attendance at camps. Screening
of patients, spleen examination and counseling for rK39
tests were correctly done at camps. However one of the
two camps in Nepal did not have an adequate supply of
rK39 kits for testing. It was also noted that patient and
camp records were inadequately maintained in 10 of 19
camps in India whereas in Bangladesh the results of
spleen examination were not recorded correctly. Clinical
skills of medical officers in spleen examination in India
were observed to be inadequate as they tended to in-
correctly record splenic enlargement. District/National
program managers in group discussions listed delayed
budgetary sanctions, inadequate time and resources to
prepare for camp activities, inadequate training and su-
pervision as major challenges in implementing the camp
search strategy.
In Nepal, the index case search strategy conducted for
45 index VL cases did not yield any new VL case while a
similar search around 36 index cases in India yielded 3
new VL cases (average 0.08 new VL case per index case
search) and 1 new PKDL case (average 0.03 new PKDL
case per index case search) (Table 2). All newly identi-
fied VL and PKDL cases in India initiated and completedTable 2 Index case search intervention carried out by health
implemented by Bangladesh)
No. of index cases identified
Total no. of households (population) screened
Detection of VL
- fever >2 weeks
- rK39 test done
- rK39 test positive
- referred for treatment
- completed treatment
- No. of new VL cases detected
- No. of new VL cases detected per index case search
Detection of PKDL
- with suspected skin lesions
- rK39 test done
- rK39 test positive
- referred for treatment
- completed treatment
- No. of new PKDL cases detected
- No. of new PKDL cases detected per index case searchtreatment. A qualitative assessment of the index case
search strategy showed that health workers in Nepal
though trained did not perform a spleen examination or
rK39 test during household screening and instead re-
ferred a suspected patient with fever for more than
2 weeks to the health center for further management.Costs
Table 3 shows the costs related to camp search strategy
for detection of VL and PKDL cases. The cost per camp
was US$ 283, US$ 349 and US$ 688 in Bangladesh, India
and Nepal respectively. Cost per detection of new case
was highest in India (US$ 1046) followed by Nepal (US$
459) and Bangladesh (US$ 105). Training start-up costs
accounted for 57% of total costs in Nepal, 69% in India
and 79% of total costs in Bangladesh. The cost per detec-
tion of new case was lower (Nepal – US$ 199, India – US
$ 320, Bangladesh – US$ 22) if training costs were ex-
cluded. Costs for IEC activities varied between 1 to 3% of
total camp search strategy costs.
The cost per new case detected by the index case search
strategy was US$ 1311 of which transport accounted for
62% and personnel (per diems) accounted for 32%. Train-
ing costs accounted for 4% of total costs (Table 4). No new
VL or PKDL case was detected in Nepal using this strat-
egy but the cost was about US$ 4 per household searched
in Nepal. The absolute cost of index search was US$ 97
and US$ 91 in India and Nepal respectively (Table 4).services in India and Nepal (Index case search was not
India Nepal
36 45
1627 (9470) 1046 (7091)
0.3% (29/9470) 0% (0/7091)
100% (29/29) –
10% (03/29) –
100% (3/3) –
100% (3/3) –
3 0
.08 0
0.01% (1/9470) 0% (0/7091)
100% (1/1) –
100% (1/1) –
100% (1/1) –
100% (1/1) –
1 0
.03 0
Table 3 Costs equivalent to USD in 2010 for camp search strategy in Bangladesh, India and Nepal (Figures in
parenthesis are% of total cost)
Bangladesh (USD) India$ (USD) Nepal (USD)
Training 4448 (79%) 2177 (69%) 778 (57%)
Communication & social mobilization 191 (3%) 59 (2%) 23 (1%)
Camp day activities 1022 (18%) 902 (29%) 575 (42%)
Total cost 5661 3138 1376
- cost per camp 283 349 688
- cost per new case detected 105 1046 459
- cost per camp (excl. training costs) 61 107 299
- cost per new case detected (excl. training cost) 22 320 199
$ Nine out of 19 camps where 3 new cases were identified are included in the cost analysis.
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Our study highlights challenges faced by national pro-
grams for VL elimination in adapting ACD strategies for
early case detection and treatment in Bangladesh, India
and Nepal. Overall, the camp search strategy was super-
ior to the index search strategy in terms of costs as well
as yield comparable with earlier evidence [11]. Camps
conducted by health services in Bangladesh showed
lower sensitivity compared to those conducted by re-
searchers in an earlier study [11]. The number of new
cases identified through the camp strategy could have
been up to 60% higher especially in Bangladesh if camp
awareness and promotional activities were done ad-
equately. This was also reflected in practice where less
than 3% of the total program expenditure for imple-
menting the ACD strategy was spent on IEC and related
activities. Spleen examination by a medical officer in a
camp setting or by a health worker at the household
level was another challenge. A large proportion of pa-
tients (95% in India, 30% in Bangladesh) with fever for
more than 2 weeks and diagnosed with splenomegaly
had a negative rK39 test. This was most likely due to
poor skills of the medical officers in clinical examination
for spleen size as observed by the researchers during theTable 4 Costs equivalent to USD in 2010 for index case
search strategy in India and Nepal
India$ (USD) Nepal (USD)
Training 109 (4%) 259 (6%)
Personnel 832 (32%) 2656 (65%)
Transport 1630 (62%) 1202 (29%)
rK39 kits 47 (2%) 0 (0%)
Total cost 2622 4117
- cost per new case detected 1311 –
- cost per household searched 3 4
-cost per index case search 97 91
Figures in parenthesis are% of total cost (Bangladesh did not implement index
case strategy).
$ Twenty-seven out of 36 index case search where 2 new cases were identified
from 950 households are included in the cost analysis.camp especially in India. This subjected a large propor-
tion of patients to unnecessary testing with rK39. On
the other hand, an alternative cause for chronic fever
and splenomegaly with a negative rK39 test cannot be
ruled out. Another major challenge seen in Bangladesh
was the high proportion (two-thirds) of newly identified
patients who did not avail of the referral and initiate and
complete treatment. Interestingly, the cost of detection
of a new case was substantially higher in India compared
to Nepal and Bangladesh and also compared to an earlier
study where ACD strategies were implemented directly
by researchers in collaboration with the health services
[11]. The higher cost could be due to the larger area
(complete district) covered by the health services, the
higher number of staff involved in the camps, the lower
number of VL cases detected and some other contextual
costs. Lastly, our study continues to document the large
burden of PKDL in Bangladesh seen in earlier studies
[9,11].
Our study had a few limitations. The index case search
strategy could not be evaluated in Bangladesh as the
health system had not yet adopted it as a strategy into
their program. The evaluation of the camp search strat-
egy in Bangladesh was based on retrospective interview-
ing of the camp team and camp attendees rather than
based on direct observations of activities before and dur-
ing the camp.Conclusions
Our study concludes that national programs can adapt
ACD strategies for detection of more VL/PKDL cases.
However adequate time and resources are required for
training, planning and strengthening referral services to
overcome challenges faced by the programs in conduct-
ing ACD.
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